Recursion Pharmaceuticals, Inc. - RXRX

Include option trades

Include indirect trades

EDGAR CIK

1 Month 3 Month 6 Month 1 Year 2 Years

Buy Breakdown

No buy transactions for this time period.

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
08/18/2025	08/19/2025	Khan Najat Chief R&D Commercial Officer Officer Director	Sell	-36,599 @ $5.52	($202,172.88)	668,197	(-5.19%)	Direct
03/27/2025 10b5-1	03/28/2025	Gibson Christopher Chief Executive Officer CEO Director	Sell	-138,574 @ $6.04	($836,986.96)	1,117,450	(-11.03%)	Direct